What is Forteo?
Forteo is a brand-name prescription drug containing teriparatide. It is used to treat osteoporosis in certain individuals, including postmenopausal women at high risk for fractures and men who have low bone mass and are at high risk for fractures. Forteo is also indicated for the treatment of primary osteoporosis or osteoporosis associated with sustained high-dose glucocorticoid therapy in postmenopausal women and men at high risk for fractures. [1][2] Teriparatide is a form of parathyroid hormone (PTH) that is administered daily by injection. [1]
How does Forteo work to treat osteoporosis?
Forteo works by stimulating bone formation. It acts as an anabolic agent, meaning it helps build bone. Teriparatide, the active ingredient in Forteo, is a polypeptide hormone that stimulates osteoblasts, the cells responsible for building new bone. It also increases the absorption of calcium and phosphate from the intestines and reduces their excretion by the kidneys, which further supports bone mineralization. [1][3]
What is the typical treatment duration for Forteo?
The recommended duration of Forteo treatment is typically 24 months. [1] However, the maximum duration of treatment with Forteo has not been established. [4]
When does the patent for Forteo expire?
The patent landscape for Forteo, and its active ingredient teriparatide, is complex and has evolved over time. While specific patent expiry dates can vary based on individual patents and any associated extensions or legal challenges, drug patent information can be tracked through resources like DrugPatentWatch.com. [5]
Are there generic versions of Forteo available?
Yes, generic versions of teriparatide are available. [6] These generic products are typically available after the expiration of relevant patents and exclusivity periods.
What are the potential side effects of Forteo?
Common side effects reported with Forteo include nausea, abdominal pain, and arthralgia (joint pain). [1] Some individuals may also experience dizziness, headache, fatigue, and injection site reactions. [2] In rare cases, more serious side effects have been reported, and patients should discuss any concerns with their healthcare provider. [1][2]
What clinical data supports the use of Forteo?
Clinical trials have demonstrated Forteo's efficacy in reducing the risk of vertebral and non-vertebral fractures in patients with osteoporosis. Studies have shown significant increases in bone mineral density (BMD) in the lumbar spine and hip following treatment with teriparatide. [1][3]
Who manufactures Forteo?
Forteo is manufactured by Eli Lilly and Company. [1]